BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,890,743 | -81.3% | 408,297 | -66.6% | 0.01% | -87.2% |
| Q3 2022 | $15,419,000 | +22.0% | 1,223,721 | +2.4% | 0.05% | +14.6% |
| Q2 2022 | $12,638,000 | +61.8% | 1,194,511 | -69.4% | 0.04% | -55.4% |
| Q1 2020 | $7,811,000 | +14364.8% | 3,905,676 | +35114.8% | 0.09% | – |
| Q4 2017 | $54,000 | -80.9% | 11,091 | -79.4% | 0.00% | -100.0% |
| Q3 2017 | $282,000 | -78.3% | 53,796 | -38.2% | 0.00% | -87.5% |
| Q2 2015 | $1,301,000 | – | 87,111 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |